BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3838513)

  • 1. 131-Iodine capsules in thyroid therapy: an individually controlled study of their uptake kinetics as compared to liquid 131-iodine.
    von Schulthess GK; Seelentag WW; Pfeiffer G; Blaeuenstein P; Bekier A
    Eur J Nucl Med; 1985; 10(1-2):25-8. PubMed ID: 3838513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid uptake of liquid versus capsule 131I tracers in hyperthyroid patients treated with liquid 131I.
    Rini JN; Vallabhajosula S; Zanzonico P; Hurley JR; Becker DV; Goldsmith SJ
    Thyroid; 1999 Apr; 9(4):347-52. PubMed ID: 10319939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation dose to patients and relatives incident to 131I therapy.
    Zanzonico PB
    Thyroid; 1997 Apr; 7(2):199-204. PubMed ID: 9133684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is standard 555 MBq 131I-therapy of hyperthyroidism ablative?
    Bertelsen J; Herskind AM; Sprogøe Jakobsen U; Hegedüs L
    Thyroidology; 1992 Dec; 4(3):103-6. PubMed ID: 1285034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved Patient Dosimetry at Radioiodine Therapy by Combining the ICRP Compartment Model and the EANM Pre-Therapeutic Standard Procedure for Benign Thyroid Diseases.
    Andersson M; Mattsson S
    Front Endocrinol (Lausanne); 2021; 12():634955. PubMed ID: 33776929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of 131I theory for 2,000 thyrotoxic patients: do the effects depend on the dose?
    Zgliczynski S; Gietka-Czernel M; Gorowski T; Bednarski A; Chomicki O; Jastrzebska W; Makowska A; Niegowska E; Pucilowska J; Soszynski P
    Exp Clin Endocrinol; 1991 May; 97(2-3):286-91. PubMed ID: 1915646
    [No Abstract]   [Full Text] [Related]  

  • 7. [Metabolic radiotherapy of hyperthyroidism].
    Salvatore M; Brunetti A
    Ann Ital Chir; 1989; 60(5):367-71. PubMed ID: 2699388
    [No Abstract]   [Full Text] [Related]  

  • 8. Radioiodine therapy of benign thyroid disorders: what are the effective thyroidal half-life and uptake of 131I?
    Kobe C; Eschner W; Wild M; Rahlff I; Sudbrock F; Schmidt M; Dietlein M; Schicha H
    Nucl Med Commun; 2010 Mar; 31(3):201-5. PubMed ID: 19907353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calculation of the radioiodine dose for the treatment of Graves' hyperthyroidism: is more than seven-thousand rad target dose necessary?
    Bajnok L; Mezosi E; Nagy E; Szabo J; Sztojka I; Varga J; Galuska L; Leovey A
    Thyroid; 1999 Sep; 9(9):865-9. PubMed ID: 10524564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The importance of the radioiodine test for the calculation of the therapeutic dose in benign thyroid diseases].
    Nüchel C; Boddenberg B; Schicha H
    Nuklearmedizin; 1993 Apr; 32(2):91-8. PubMed ID: 8479936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Follow-up on thyroidal uptake after radioiodine therapy: how robust is the peri-therapeutic dosimetry?
    Eschner W; Kobe C; Schicha H
    Z Med Phys; 2011 Dec; 21(4):258-65. PubMed ID: 21719262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioactive iodine therapy in Graves' hyperthyroidism: a prospective study from a tertiary referral centre in north India.
    Sankar R; Sekhri T; Sripathy G; Walia RP; Jain SK
    J Assoc Physicians India; 2005 Jul; 53():603-6. PubMed ID: 16190128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Behavior of serum triiodothyronine in subjects treated with I-131 for hyperthyroidism].
    Bagnasco M; Biassoni P; Clemente GF; Vibracci G; Ferrini O
    Arch Maragliano Patol Clin; 1975; 31(1):77-87. PubMed ID: 1244069
    [No Abstract]   [Full Text] [Related]  

  • 14. [Gamma dose estimation to the gastric wall after administration of a capsule containing a large dose of 131I (author's transl)].
    Oyamada H; Fukukita H; Kawachi K; Kawai H; Nagaiwa K; Terui S; Ebihara S
    Radioisotopes; 1980 May; 29(5):227-32. PubMed ID: 7414013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 131I therapy of toxic and non-toxic goiters.
    Beckers C
    Q J Nucl Med; 1999 Dec; 43(4):291-6. PubMed ID: 10731779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Follow-up of solitary autonomous thyroid nodules treated with 131I.
    Goldstein R; Hart IR
    N Engl J Med; 1983 Dec; 309(24):1473-6. PubMed ID: 6646172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of radioiodine (131/125I) therapy of hyperthyroidism.
    Glanzmann C; Horst W; Magdeburg W
    Radiol Clin (Basel); 1975; 44(5):484-90. PubMed ID: 1208842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Radioiodine (131I) as the only treatment of hyperthyroidism. Results of 10 years of experience].
    Hennen G; McNamara EM; Dockier A; Joachim M
    Rev Med Liege; 1999 Jul; 54(7):611-7. PubMed ID: 10495684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased uptake after fractionated ablative doses of iodine-131.
    Wu HS; Hseu HH; Lin WY; Wang SJ; Liu YC
    Eur J Nucl Med Mol Imaging; 2005 Feb; 32(2):167-73. PubMed ID: 15351912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioiodine treatment of hyperthyroidism in patients with low thyroid uptake.
    Ruchała M; Sowiński J; Dolata M; Junik R; Gembicki M; Skiba A
    Nucl Med Rev Cent East Eur; 2005; 8(1):28-32. PubMed ID: 15977144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.